EcoDrugPlus

Hypocretin Receptor 2

Ensembl ID : ENSCDRG00005014448
Gene Symbol: HCRTR2
3 Cross references
199 Possible Orthologues:

Indoleamine 2,3-Dioxygenase 1

Ensembl ID : ENSCDRG00005009435
Gene Symbol: IDO1
3 Cross references
98 Possible Orthologues:

Inhibitor Of Nuclear Factor Kappa B Kinase Subunit Beta

Ensembl ID : ENSCDRG00005019600
Gene Symbol: IKBKB
1 Cross references
197 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 1

Ensembl ID : ENSCDRG00005006025
Gene Symbol: IMPDH1
1 Cross references
332 Possible Orthologues:

Inosine Monophosphate Dehydrogenase 2

Ensembl ID : ENSCDRG00005004218
Gene Symbol: IMPDH2
3 Cross references
202 Possible Orthologues:

Inositol Polyphosphate-5-Phosphatase D

Ensembl ID : ENSCDRG00005009359
Gene Symbol: INPP5D
3 Cross references
214 Possible Orthologues:

Insulin Like Growth Factor 1 Receptor

Ensembl ID : ENSCDRG00005019740
Gene Symbol: IGF1R
1 Cross references
276 Possible Orthologues:

Insulin Receptor

Ensembl ID : ENSCDRG00005016879
Gene Symbol: INSR
3 Cross references
290 Possible Orthologues:

Integrin Subunit Alpha 2b

Ensembl ID : ENSCDRG00005003803
Gene Symbol: ITGA2B
3 Cross references
191 Possible Orthologues:

Integrin Subunit Alpha 4

Ensembl ID : ENSCDRG00005005689
Gene Symbol: ITGA4
1 Cross references
237 Possible Orthologues:

Integrin Subunit Alpha 5

Ensembl ID : ENSCDRG00005003372
Gene Symbol: ITGA5
3 Cross references
267 Possible Orthologues:

Integrin Subunit Alpha V

Ensembl ID : ENSCDRG00005008520
Gene Symbol: ITGAV
1 Cross references
243 Possible Orthologues:

Select Keywords:


PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains. Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).

PREMIER has received funding from the Innovative Medicines Initiative 2 Joint Undertaking (JU) under grant agreement No 875508. The JU receives support from the EU’s Horizon 2020 research and innovation programme and the European Federation of Pharmaceutical Industries and Associations (EFPIA). The views reflect only the authors’ perspective and the JU is not responsible for any use that may be made of the information this manuscript contains.

Elements of the website have been developed under projects PREMIER and the Biocenter Finland Drug Discovery and Chemical Biology network. CSC-IT is thanked for providing computational resources. Content of the website is provided without guarantee for correctness. Data has been collected and integrated from multiple public sources, for the largest: FDA, HUGO Gene Nomenclature Committee, ChEMBL, IUPHAR/BPS guide to pharmacology, Reactome, UniProt, and Ensembl. Credit is given to Ensembl for collecting species images (provided under public domain licences such as Wikimedia and NHGRI).